Mexico - Delayed Quote MXN

Chugai Pharmaceutical Co., Ltd. (4519N.MX)

1,121.87

0.00

(0.00%)

As of April 24 at 7:52:50 AM CST. Market Open.

Global Pharma Stocks Fall as Trump Plans to Cut Drug Prices

Novo Nordisk, which generates around 60% of its sales in the U.S., is among the biggest losers in early European trade.

The Wall Street Journal 24 days ago

069620.KS

CHGCF

CHGCY
Chugai Pharmaceutical Co. (CHGCY) Upgraded to Buy: Here's Why

Chugai Pharmaceutical Co. (CHGCY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks last month

CHGCF

CHGCY

Performance Overview

Return	4519N.MX	Nikkei 225 (^N225)
YTD	+15.45%	-5.87%
1-Year	+15.45%	-2.43%
3-Year	+15.45%	+35.28%